EVH Evolent Health Inc - Class A

  1. Stocks
  2. Healthcare
  3. NYSE: EVH

Price (delayed)

$4.74

Market cap

$535.9M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.49

Enterprise value

$1.36B

?
Relative Growth: Rel. Growth: 30
Relative Strength: Rel. Strength: 62
Relative Valuation: Rel. Valuation: 39
Relative Profitability: Rel. Profitability: 6

Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers ...

Highlights
The EPS has shrunk by 181% YoY but it rose by 4.1% QoQ
The quick ratio has grown by 25% YoY but it has contracted by 6% from the previous quarter
The company's equity has shrunk by 57% YoY and by 3.3% QoQ
The debt has increased by 14% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.evolenthealth.com
Peers: NHC CPRT GHC ARMK

Key stats

What are the main financial stats of EVH

EVH stock price

How has the Evolent Health Inc - Class A stock price performed over time
Intraday
0.85%
1 week
1.28%
1 month
-18.97%
1 year
-45.95%
YTD
18.5%
QTD
-12.55%

Financial performance

How have Evolent Health Inc - Class A's revenue and profit performed over time
Revenue
$2.1B
Gross profit
$361.64M
Operating income
-$423.94M
Net income
-$504.99M
Gross margin
17.2%
Net margin
-24.1%
The gross margin has contracted by 15% from the previous quarter but it has grown by 4.9% YoY
The revenue has grown by 11% from the previous quarter but it has contracted by 4.5% YoY
The net margin has increased by 8% QoQ
The operating margin has increased by 7% from the previous quarter

Price vs fundamentals

How does EVH's price correlate with its fundamentals

Growth

What is Evolent Health Inc - Class A's growth rate over time

Valuation

What is Evolent Health Inc - Class A stock price valuation
P/E
N/A
P/B
1.39
P/S
0.25
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.65
The EPS has shrunk by 181% YoY but it rose by 4.1% QoQ
The company's equity has shrunk by 57% YoY and by 3.3% QoQ
EVH's price to book (P/B) is 49% lower than its 5-year quarterly average of 2.7 but 26% higher than its last 4 quarters average of 1.1
The price to sales (P/S) is 83% lower than the 5-year quarterly average of 1.5 and 17% lower than the last 4 quarters average of 0.3
The revenue has grown by 11% from the previous quarter but it has contracted by 4.5% YoY

Efficiency

How efficient is Evolent Health Inc - Class A business performance
EVH's return on invested capital has dropped by 176% year-on-year but it is up by 6% since the previous quarter
The ROE has contracted by 20% from the previous quarter
The ROS rose by 10% QoQ

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health Inc - Class A financials performed over time
The company's total assets is 24% higher than its total liabilities
The quick ratio has grown by 25% YoY but it has contracted by 6% from the previous quarter
The company's current ratio rose by 23% YoY but it fell by 6% QoQ
The debt is 153% higher than the equity
EVH's debt to equity has surged by 166% year-on-year
The company's equity has shrunk by 57% YoY and by 3.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.